Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Henry

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancerRobert F Wolff, Steve Ryder, Alberto Bossi, et al.
BJU International|November 29, 2020
Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penisMichael Ager, Kelechi Njoku, Maria Serra, et al.
La Radiologia Medica|July 2, 2025
Combining MRI radiomics, hypoxia gene signature score and clinical variables for prediction of biochemical recurrence-free survival after radiotherapy in prostate cancerJim Zhong, Angela Davey, Russell Frood, et al.
Advances in Radiation Oncology|April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Advances in Radiation Oncology|November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder CancerMartin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al.
Physics in Medicine and Biology|February 25, 2021
IPEM Topical Report: an international IPEM survey of MRI use for external beam radiotherapy treatment planningRichard Speight, Marcus Tyyger, Maria A Schmidt, et al.
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
The Lancet. Oncology|January 2, 2021
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation studyAnastasia Chalkidou, Thomas Macmillan, Mariusz T Grzeda, et al.
Frontiers in Oncology|March 11, 2020
Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single CentreSue Cheeseman, Matthew Thompson, Will Sopwith, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancerRobert F Wolff, Steve Ryder, Alberto Bossi, et al.
BJU International|November 29, 2020
Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penisMichael Ager, Kelechi Njoku, Maria Serra, et al.
La Radiologia Medica|July 2, 2025
Combining MRI radiomics, hypoxia gene signature score and clinical variables for prediction of biochemical recurrence-free survival after radiotherapy in prostate cancerJim Zhong, Angela Davey, Russell Frood, et al.
Advances in Radiation Oncology|April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Advances in Radiation Oncology|November 4, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder CancerMartin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al.
Physics in Medicine and Biology|February 25, 2021
IPEM Topical Report: an international IPEM survey of MRI use for external beam radiotherapy treatment planningRichard Speight, Marcus Tyyger, Maria A Schmidt, et al.
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
The Lancet. Oncology|January 2, 2021
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation studyAnastasia Chalkidou, Thomas Macmillan, Mariusz T Grzeda, et al.
Frontiers in Oncology|March 11, 2020
Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single CentreSue Cheeseman, Matthew Thompson, Will Sopwith, et al.
Pageof 8